225 related articles for article (PubMed ID: 22560665)
1. DNA damage in an animal model of maple syrup urine disease.
Scaini G; Jeremias IC; Morais MO; Borges GD; Munhoz BP; Leffa DD; Andrade VM; Schuck PF; Ferreira GC; Streck EL
Mol Genet Metab; 2012 Jun; 106(2):169-74. PubMed ID: 22560665
[TBL] [Abstract][Full Text] [Related]
2. Melatonin ameliorates oxidative stress and DNA damage of rats subjected to a chemically induced chronic model of Maple Syrup Urine Disease.
Wessler LB; Ise K; Lemos IC; Rezende VL; Duarte MB; Damiani AP; de Oliveira J; de Andrade VM; Streck EL
Metab Brain Dis; 2020 Aug; 35(6):905-914. PubMed ID: 32297169
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease.
Scaini G; Teodorak BP; Jeremias IC; Morais MO; Mina F; Dominguini D; Pescador B; Comim CM; Schuck PF; Ferreira GC; Quevedo J; Streck EL
Behav Brain Res; 2012 May; 231(1):92-6. PubMed ID: 22433584
[TBL] [Abstract][Full Text] [Related]
4. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
[TBL] [Abstract][Full Text] [Related]
5. L-Carnitine supplementation decreases DNA damage in treated MSUD patients.
Mescka CP; Guerreiro G; Hammerschmidt T; Faverzani J; de Moura Coelho D; Mandredini V; Wayhs CA; Wajner M; Dutra-Filho CS; Vargas CR
Mutat Res; 2015 May; 775():43-7. PubMed ID: 25867118
[TBL] [Abstract][Full Text] [Related]
6. L-carnitine Prevents Oxidative Stress in the Brains of Rats Subjected to a Chemically Induced Chronic Model of MSUD.
Mescka CP; Rosa AP; Schirmbeck G; da Rosa TH; Catarino F; de Souza LO; Guerreiro G; Sitta A; Vargas CR; Dutra-Filho CS
Mol Neurobiol; 2016 Nov; 53(9):6007-6017. PubMed ID: 26526843
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
[TBL] [Abstract][Full Text] [Related]
8. Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model.
Scaini G; Comim CM; Oliveira GM; Pasquali MA; Quevedo J; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Bogo MR; Streck EL
J Inherit Metab Dis; 2013 Sep; 36(5):721-30. PubMed ID: 23109061
[TBL] [Abstract][Full Text] [Related]
9. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of acetylcholinesterase in an animal model of maple syrup urine disease.
Scaini G; de Rochi N; Jeremias IC; Deroza PF; Zugno AI; Pereira TC; Oliveira GM; Kist LW; Bogo MR; Schuck PF; Ferreira GC; Streck EL
Mol Neurobiol; 2012 Apr; 45(2):279-86. PubMed ID: 22328136
[TBL] [Abstract][Full Text] [Related]
11. Intrahippocampal administration of the branched-chain alpha-hydroxy acids accumulating in maple syrup urine disease compromises rat performance in aversive and non-aversive behavioral tasks.
Vasques Vde C; Brinco F; Wajner M
J Neurol Sci; 2005 May; 232(1-2):11-21. PubMed ID: 15850577
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective Effect of Creatine and Pyruvate on Enzyme Activities of Phosphoryl Transfer Network and Oxidative Stress Alterations Caused by Leucine Administration in Wistar Rats.
Rieger E; de Franceschi ID; Preissler T; Wannmacher CMD
Neurotox Res; 2017 Nov; 32(4):575-584. PubMed ID: 28612295
[TBL] [Abstract][Full Text] [Related]
13. Administration of branched-chain amino acids increases the susceptibility to lipopolysaccharide-induced inflammation in young Wistar rats.
Wessler LB; de Miranda Ramos V; Bittencourt Pasquali MA; Fonseca Moreira JC; de Oliveira J; Scaini G; Streck EL
Int J Dev Neurosci; 2019 Nov; 78():210-214. PubMed ID: 31330240
[TBL] [Abstract][Full Text] [Related]
14. Cerebral Oedema, Blood-Brain Barrier Breakdown and the Decrease in Na(+),K(+)-ATPase Activity in the Cerebral Cortex and Hippocampus are Prevented by Dexamethasone in an Animal Model of Maple Syrup Urine Disease.
Rosa L; Galant LS; Dall'Igna DM; Kolling J; Siebert C; Schuck PF; Ferreira GC; Wyse ATS; Dal-Pizzol F; Scaini G; Streck EL
Mol Neurobiol; 2016 Aug; 53(6):3714-3723. PubMed ID: 26133302
[TBL] [Abstract][Full Text] [Related]
15. In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease.
Mescka C; Moraes T; Rosa A; Mazzola P; Piccoli B; Jacques C; Dalazen G; Coelho J; Cortes M; Terra M; Regla Vargas C; Dutra-Filho CS
Metab Brain Dis; 2011 Mar; 26(1):21-8. PubMed ID: 21380499
[TBL] [Abstract][Full Text] [Related]
16. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
Funchal C; Latini A; Jacques-Silva MC; Dos Santos AQ; Buzin L; Gottfried C; Wajner M; Pessoa-Pureur R
Neurochem Int; 2006 Dec; 49(7):640-50. PubMed ID: 16822590
[TBL] [Abstract][Full Text] [Related]
17. A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies.
Bridi R; Fontella FU; Pulrolnik V; Braun CA; Zorzi GK; Coelho D; Wajner M; Vargas CR; Dutra-Filho CS
J Neurosci Methods; 2006 Sep; 155(2):224-30. PubMed ID: 16530844
[TBL] [Abstract][Full Text] [Related]
18. Definition of the mutation responsible for maple syrup urine disease in Poll Shorthorns and genotyping Poll Shorthorns and Poll Herefords for maple syrup urine disease alleles.
Dennis JA; Healy PJ
Res Vet Sci; 1999 Aug; 67(1):1-6. PubMed ID: 10425233
[TBL] [Abstract][Full Text] [Related]
19. Genome instability in Maple Syrup Urine Disease correlates with impaired mitochondrial biogenesis.
Strand JM; Skinnes R; Scheffler K; Rootvelt T; Woldseth B; Bjørås M; Eide L
Metabolism; 2014 Aug; 63(8):1063-70. PubMed ID: 24928662
[TBL] [Abstract][Full Text] [Related]
20. Branched-chain amino acids (BCAA) administration increases autophagy and the autophagic pathway in brain tissue of rats submitted to a Maple Syrup Urine Disease (MSUD) protocol.
Fermo KT; da Silva Lemos I; Farias HR; Rosso MP; Effting PS; Leipnitz G; Streck EL
Metab Brain Dis; 2023 Jan; 38(1):287-293. PubMed ID: 36305998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
